Nothing Special   »   [go: up one dir, main page]

AU5108693A - Gestagen-effective 4,5;11,12-estradienes, process for their production, medicaments containing these estradienes and their use in producing medicaments - Google Patents

Gestagen-effective 4,5;11,12-estradienes, process for their production, medicaments containing these estradienes and their use in producing medicaments

Info

Publication number
AU5108693A
AU5108693A AU51086/93A AU5108693A AU5108693A AU 5108693 A AU5108693 A AU 5108693A AU 51086/93 A AU51086/93 A AU 51086/93A AU 5108693 A AU5108693 A AU 5108693A AU 5108693 A AU5108693 A AU 5108693A
Authority
AU
Australia
Prior art keywords
estradienes
medicaments
gestagen
effective
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51086/93A
Inventor
Karl-Heinrich Fritzemeier
Wolfgang Halfbrodt
Rolf Krattenmacher
Gunter Neef
Eckhard Ottow
Klaus Schollkopf
Wolfgang Schwede
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU5108693A publication Critical patent/AU5108693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
AU51086/93A 1992-09-22 1993-09-22 Gestagen-effective 4,5;11,12-estradienes, process for their production, medicaments containing these estradienes and their use in producing medicaments Abandoned AU5108693A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4232521 1992-09-22
DE19924232521 DE4232521A1 (en) 1992-09-22 1992-09-22 Progestagenic 4,5; 11,12-estradienes, processes for their preparation, medicaments containing these estradienes and their use for the production of medicaments
PCT/EP1993/002573 WO1994006819A1 (en) 1992-09-22 1993-09-22 Gestagen-effective 4,5;11,12-estradienes, process for their production, medicaments containing these estradienes and their use in producing medicaments

Publications (1)

Publication Number Publication Date
AU5108693A true AU5108693A (en) 1994-04-12

Family

ID=6469058

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51086/93A Abandoned AU5108693A (en) 1992-09-22 1993-09-22 Gestagen-effective 4,5;11,12-estradienes, process for their production, medicaments containing these estradienes and their use in producing medicaments

Country Status (3)

Country Link
AU (1) AU5108693A (en)
DE (1) DE4232521A1 (en)
WO (1) WO1994006819A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271004B (en) * 1994-09-09 1997-05-26 Ind Chimica Srl PROCESS FOR THE PREPARATION OF GESTODENE
DE102007063503A1 (en) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-hydroxy-19-nor-21-carboxylic acid steroid y-lactone derivative, its use and the derivative-containing drug
DE102007063500A1 (en) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17- (1'-Propenyl) -17-3'-oxidoestra-4-en-3-one derivative, its use and the derivative-containing drug

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069440A (en) * 1961-10-27 1962-12-18 American Cyanamid Co New 17-oxygenated-delta"-progesterones
NL124135C (en) * 1963-02-20
AU5958469A (en) * 1969-08-15 1971-02-18 Gd. Searle & Co 3-(3-OXO-11B, 13a-DIALKYL-176-HYDROXYGON-4-EN-17 &-YL) PROPIONIC ACIDr - LACTONE
FR2215416B1 (en) * 1973-01-29 1976-09-10 Roussel Uclaf
US3892855A (en) * 1973-10-10 1975-07-01 Searle & Co Method for fertile breeding control in female bovine
DE2558076C2 (en) * 1975-12-19 1983-12-15 Schering AG, 1000 Berlin und 4709 Bergkamen Depot steroid esters, processes for their production and pharmaceutical preparations containing them
DE3042529A1 (en) * 1980-11-07 1982-06-24 Schering Ag, 1000 Berlin Und 4619 Bergkamen 11-METHYLENE (DELTA) (UP ARROW) 1 (UP ARROW) (UP ARROW) 5 (UP ARROW) STEROIDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE3260444D1 (en) * 1981-04-16 1984-08-30 Richter Gedeon Vegyeszet Process for the preparation of pregn-4-ene-3,20-dione derivatives and 17-alpha-ethynyl-17-beta-trifluoroacetoxy-gon-4-ene-3-one derivatives, and pharmaceutical compositions containing the latter compounds
DE3214689A1 (en) * 1982-04-16 1983-10-27 Schering AG, 1000 Berlin und 4709 Bergkamen 11SS CHLORINE STEROIDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE3214690A1 (en) * 1982-04-16 1983-10-27 Schering AG, 1000 Berlin und 4709 Bergkamen 11SS CHLORINE (DELTA) (UP ARROW) 1 (UP ARROW) (UP ARROW) 5 (UP ARROW) STEROIDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
GB8313921D0 (en) * 1983-05-19 1983-06-22 World Health Org Contraceptive compositions
DE3410880A1 (en) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-SUBSTITUTED ESTRADIENE AND ESTRATRIENE
DE3710728A1 (en) * 1987-03-31 1988-10-13 Schering Ag METHOD FOR PRODUCING 17 (ALPHA) -ETHINYL-17SS-HYDROXY-18-METHYL-4.15-ESTRADIEN-3-ON AND THE NEW INTERMEDIATE PRODUCTS FOR THIS METHOD

Also Published As

Publication number Publication date
DE4232521A1 (en) 1994-03-24
WO1994006819A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
AU694647B2 (en) Acetamide derivatives, process for producing the same, and medicinal composition containing the same
HUT70616A (en) Carboxamides, pharmaceutical compositions containing them and process for producing them
HU904670D0 (en) Process for producing 11,15-diacyl-prostaglandines reducing internal pressure in eyeballs and pharmaceutical preparatives containing these compounds
AU6526190A (en) 2-bicyclo-benzimidazoles, process for their production and drugs containing said compounds
HUP9601529A3 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9900055A3 (en) 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridin -derivatives, process for producing them and pharmaceutical compositions containing them
HUT49366A (en) Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same
AU2843592A (en) 3,9-diphosphaspiroundecanes and process for making 3,9-diphosphaspiroundecanes
HU9400109D0 (en) 9h-imidazo[1,2-a]benzimidazol-3-acetamide derivatives, process for producing them and pharmaceutical containing them
AU3644489A (en) Novel pigments, process for their production and their use
HU9400934D0 (en) Thiadiazinone derivatives, pharmaceutical compositions containing them and process for producing them
HU9302727D0 (en) Piperidine derivatives, process for producing them and their therapeutical use
AU4601493A (en) Hydroxyalkylchitosan salt, production process thereof and cosmetic composition containing the same
AU4341689A (en) Polymer composition and process for producing the same
EP0410554A3 (en) 14,17-alpha-ethano- and ethano-estratrienes, process for their production and their use in the production of pharmaceuticals
AU5108693A (en) Gestagen-effective 4,5;11,12-estradienes, process for their production, medicaments containing these estradienes and their use in producing medicaments
AU4817490A (en) 2',3'-dideoxyribofuranosides and process for producing them
AU8107394A (en) 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceuticals containing them and process for their production
HU9401190D0 (en) 2,6-disubstituted-4-quinolyl-dihydropyridine derivatives, process for producing them and use of them in pharmaceuticals
HU9402919D0 (en) Heteroaryl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them
AU3205893A (en) New 4-cinnolinyl- and 4-naphthyridinyl-dihydropyridines, processes for their use in medicaments
AU647608B2 (en) Isoxazolylimidazole derivatives, process for their production and their use in pharmaceutical agents
AU9025291A (en) Renin-inhibiting peptides of the cyclohexylstatin type, process for producing the same and their use in medicaments
AU4458489A (en) 1-aminoalkyl-3-oxysubstituted-4-aryl-1,3,4,5-tetrahydro-2h- 1,3-benzodiazepine-2-ones, a process for their preparation and their use as medicaments
AU2886595A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing the latter, as well as process for the production of the complexes and agents